Clinical Trials Search Results

Results 31-40 of 351 for your search
Show Search Criteria
Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent / Refractory Solid Tumors
Status: Active
Age: 2 to 20 years
Gender: Male or Female
Location: 13 locations
Nivolumab in Treating Patients with Metastatic or Recurrent Uterine Cancer
Status: Active
Age: 18 years and over
Gender: Female
Location: 7 locations
Durvalumab with or without Tremelimumab in Treating Patients with Recurrent or Persistent Endometrial Cancer
Status: Active
Age: 18 years and over
Gender: Female
Location: 7 locations
Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101)
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 7 locations
Dose-Escalation and Dose-Expansion of RMC-4630 and Cobimetinib in Relapsed / Refractory Solid Tumors
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 8 locations
TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 7 locations
A Study of XmAb®22841 Monotherapy & in Combination w / Pembrolizumab in Subjects w / Selected Advanced Solid Tumors
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 7 locations
Durvalumab vs Placebo Following Stereotactic Body Radiation Therapy in Early Stage Non-small Cell Lung Cancer Patients
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 14 locations